No effect of a low dose of omega-3 on the lipid profile of pregnant women with obesity: a randomized trial
Nenhum efeito de uma dose baixa de ômega-3 no perfil lipídico de gestantes obesas: um ensaio clínico randomizado
DOI:
https://doi.org/10.53660/CLM-1700-23L21Palavras-chave:
Pregnancy, Triglycerides, Omega-3, Obesity, GlucoseResumo
Objective: Evaluate the lipid profile, fasting blood glucose, Body Mass Index (BMI) and weight gain of pregnant women with obesity and the effect of a low dose (1,1 g/day) of omega-3 on these parameters. Methods: A randomized clinical trial was performed from May 1st, 2019 to October 31th, 2022 with pregnant women diagnosed with obesity by arrival BMI ≥ 30.0 kg/m2. The participants were randomized into two groups: omega-3 and control. All pregnant women received standard prenatal follow-up and the same diet and physical exercise instructions. Laboratory tests were performed at three different times: first moment with gestational age (GA 12-20 weeks), second (GA 24-28 weeks) and third (GA 32-34 weeks) measuring maternal serum levels of glucose, total cholesterol (TC), low density lipoprotein (LDL), high density lipoprotein (HDL) and triglycerides (TG) as well as weight gain and BMI were monitored. Results: A total of 172 pregnant women with obesity were evaluated. Of these, 87 (50.6%) composed the control group and 85 (49.4%) the omega-3 group. There was no difference of lipid profile, fasting blood glucose, BMI and weight gain values between groups during the 1st, 2nd and 3rd evaluation moments. Conclusion: Low dose (1,1 g/day) of omega-3 showed no effect on the lipid profile, fasting blood glucose, BMI and weight gain in pregnant women with obesity in omega-3 group during the evaluation moments.
Downloads
Referências
ALFADHLI, E. M. Gestational diabetes mellitus. Saudi Medical Journal, v. 36, n. 4, p. 399-406, 2015.
BRASIL. Instituto Brasileiro de Geografia e Estatística (IBGE). Pesquisa de orçamentos familiares 2008-2009: antropometria e estado nutricional de crianças, adolescentes e adultos no Brasil. Rio de Janeio: IBGE, 2010.
CESARE, M. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19 2 million participants. The Lancet, v. 387, n. 10026, p. 1377-1396, 2016.
DJAZAYERY, A.; ESHRAGHIAN, M. R.; KOOHDANI, F.; SABOOR-YARAGHI, A. A.; DERAKHSHANIAN, H.; ZAREI, M.; JAVANBAKHT, M. H.; DJALALI, M. Effects of supplementation with omega-3 on insulin sensitivity and non-esterified free fatty acid (NEFA) in type 2 diabetic patients. Arq Bras Endocrinol Metab. 2014;58/4.
GAETE MG, ATALAH ES, ARAYA JA. Efecto de la suplementación de la dieta de la madre durante la lactancia com ácidos grasos omega 3 en la composición de los lípidos de la leche. Rev Chil Pediatr. 2002; 73: 239-47.
GAETE MG, ATALAH ES. Niveles de LC-PUFA n-3 en la leche materna después de incentivar el consumo de alimentos marinos. Rev Chil Pediatr. 2003; 74: 158-65.
Gestational diabetes mellitus. Practice bulletin No. 137. Obstet Gynecol 2013; 122:406–16.
GONZÁLES MI. Ácidos grasos omega 3: benefícios y fuentes. Interciencia. 2002; 27: 128-36.
HOFFMAN DR, BIRCH EE, CASTAÑEDA YS, FAWCETT SL, WHEATON DH, BIRCH DG, UAUY R. Visual function in breastfed term infants weaned to formula with or without longchain polyunsaturates at 4 to 6 months: a randomized clinical trial. J Pediatr. 2003;142: 669-77
HORNSTRA G. Omega-3 long-chain polyunsaturated fatty acids and health benefits. Neuilly-sur-seine: Nutriscience Roche Vitamins; 2002.
IOM. INSTITUTE OF MEDICINE; NRC.NATIONAL RESEARCH COUNCIL. Weight gain during pregnancy: reexamining the guidelines. The National Academies Press. Washington (DC): The National Academies Press; 2009.
KAMPMANN, U.; MADSEN, L. R.; SKAJAA, G. O.; IVERSEN, D. S.; MOELLER, N.; OVESEN, P. Gestational diabetes: a clinical update. World Journal of Diabetes, v. 6, n. 8, p. 1065-1072, 2015.
MAFFEIS, C.; MORANDI, A. Effect of maternal obesity on foetal growth and metabolic health of the offspring. Obesity Facts, v. 10, n. 2, p. 112-117, 2017.
MAFORT, T. T.; RUFINO, R.; COSTA, C. H.; LOPES, A. J. Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function. Multidisciplinary Respiratory Medicine, v. 11, n. 1, p. 28, 2016.
MARTIN, S. S.; BLAHA, M. J.; ELSHAZLY, M. B.; TOTH, P. P.; KWITEROVICH, P. O.; BLUMENTHAL, R. S.; JONES, S. R. Comparison of a novel method vs the friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA 2013; 310:2061.
MCCABE, C. F.; PERNG, W. Metabolomics of Diabetes in Pregnancy. Current Diabetes Reports, v. 17, n. 57, p. 1-12, 2017.
MCCANCE, D. R. Diabetes in pregnancy. Best Practice & Research Clinical Obstetrics and Gynaecology, v. 29, n. 5, p. 685-699, 2015.
MISSION, J. F.; MARSHALL, N. E.; CAUGHEY, A. B. Obesity in pregnancy: a big problem and getting bigger. Obstetrical & gynecological survey, v. 68, n. 5, p. 389-399, 2013.
POULAKOS, P.; MINTZIORI, G.; TSIROU, E.; TAOUSANI, E.; SAVVAKI, D.; HARIZOPOULOU, V.; et al. Comments on gestational diabetes mellitus: from pathophysiology to clinical practice. Hormones, v. 14, n. 3, p. 335-344, 2015.
SCHULZ, K. F.; ALTMAN, D. G.; MOHER, D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340
SENAT, M.-V.; DERUELLE, P. Le diabète gestationnel. Gynécologie Obstétrique & Fertilité, v. 44, n. 4, p. 244-247, 2016.
SILVA, J. C.; AMARAL, A. R.; FERREIRA, B. S.; WILEMAN, I.; K. M.; SILVA, M. R.; SALES, W. B. Obesidade materna e suas consequências na gestação e no parto: uma revisão sistemática. FEMINA, v. 42, n. 3, p. 135-140, 2014.
VALENZUELA AB, NIETO MS. Acido docosahexaenoico (DHA) en el desarrolo fetal y en la nutrición materno-infantil. Ver Med Chile. 2001; 129: 1203-11
VERNINI, J. M.; MORELI, J. B.; MAGALHÃES, C. G.; COSTA, R. A. A.; RUDGE, M. V. C.; CALDERON, I. M. P. Maternal and fetal outcomes in pregnancies complicated by overweight and obesity. Reproductive Health 2016 13:1, v. 13, n. 1, p. 107-110, 2016.
